<?xml version="1.0" encoding="UTF-8"?>
<p id="p0175">Currently, there are numerous companies that have applied for clinical trials to repurpose existing drugs as well as to develop vaccines and drugs to fight against the fast spreading COVIDâ€“19 (
 <xref rid="bb0665" ref-type="bibr">Rudra et al., 2017</xref>). In the case of repurposing the existing drugs, randomized controlled treatment (RCT) are being carried out by various biotechnological companies as well as research organizations such as National Institutes of Health (NIH), USA to identify disease specific drugs. The major drugs undergoing clinical trials that have the potential to treat this viral infection (
 <xref rid="t0015" ref-type="table">Table 3</xref> ). More research may be required in traditional medicine to utilize them in the treatment of COVID-19.
</p>
